The Stemex Phase II/III Study: Challenges in Production and Delivery of Centrally Manufactured ex vivo Expanded Umbilical Cord Blood (UCB) CD133+ Cells to Patients With Advanced Hematological Malignancies

Autor: Snyder, D., Landau, E., Rosenheimer, N.G., Mandel, J., Glukhman, E., Hasson, N., Lador, C., Olesinski, E., Hagler-Price, G., Leshem, A., Freind, E., Ben Abu, K., Sharabi, S., Shachaf, O., Israeli, H., Harati, D., Srur-Kidron, O., Bracha, D., Peled, T.
Zdroj: In Biology of Blood and Marrow Transplantation 2011 17(2) Supplement:S305-S305
Databáze: ScienceDirect